Best Agrolife: FY26 Inventory down to 651 Cr, OPEX cut 15%

Best Agrolife Ltd. released a corporate presentation detailing its activities and strategic direction. In FY26, the company launched three patented formulations (BestmanTM, FetagenTM, Shot DownTM) and secured seven new patents. Despite a challenging Q4 due to the Gulf conflict, which led to a strategic curtailment of sales impacting ₹50-70 crore revenue, the company focused on operational discipline. It implemented two rounds of price increases in April and May 2026 to mitigate rising input costs. Key operational achievements include a significant reduction in inventory levels from ₹958 crore in FY24 to ₹651 crore by March 31, 2026, and a 15% year-on-year reduction in OPEX to ₹280 crore in FY26. The company plans to launch four more patented products in FY27 and will continue its strategy of manufacturing high-value technicals, introducing new products, and controlling expenses.